Trial intelligence / Profile preview

Rosuvastatin vs Coenzyme Q10 in NASH

NCT05731596Phase 3Unknown

Sponsor
Tanta University
Start
Jun 2023
Primary completion
Feb 2024
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of rosuvastatin, Coenzyme Q10 mucoadhesive tablets in Nonalcoholic steatohepatitis (NASH), sponsored by Tanta University. Status: unknown.

02

Drugs

rosuvastatinCoenzyme Q10 mucoadhesive tablets
03

Conditions

Nonalcoholic steatohepatitis (NASH)

Beyond the preview

Go deeper on NCT05731596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05731596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call